Supplementary Figure 2. 2-photon lifetime measurements to quantify FRET efficiency.
A) Images of HEK cells expressing Citrine either fused to QuasAr2, or targeted to the plasma membrane via a Cterminal fusion to the transmembrane domain of platelet-derived growth factor receptor (in pDisplay vector, a gift from Prof. Alice Ting, MIT). B) Decay of the electronic excited state as measured by timecorrelated single-photon counting. The shorter lifetime of the QuasAr2 construct indicated the presence of an additional decay pathway, which we ascribed to FRET from the Citrine to the QuasAr2. 
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Supplementary Figure 4.
Step response of ArcLight. ArcLight Q239 did not show a complete step response in the 100 ms holding time of a 5 Hz square wave, so the step response was measured with a 1 Hz square wave from -70 mV to +30 mV. Trace was averaged over 10 trials. ArcLight equilibration time was > 500 ms.
Supplementary Figure 5. Optimal eFRET GEVI as a function of detection band.
Based on the known emission spectra of the fluorescent proteins and the transmission spectra of our filters, we calculated the expected fluorescence signal for each eFRET GEVI in emission spectral bands 30 nm wide between 510 nm and 690 nm. We then used the scaling of shot noise with total photon counts to estimate a SNR for each eFRET GEVI in each band. The charts show the highest SNR eFRET GEVI for each band, for detection of A) Square waves in HEK cells (-70 mV to +30 mV), or B) single APs in cultured neurons. G = EGFP, C = Citrine, O = mOrange2, R = mRuby2. This figure does not incorporate wavelength-dependent differences in available laser power and stability, spectral sensitivity of camera response, spectrum of background autofluorescence, tolerance of the reporter to photobleaching, and tolerance of the sample to phototoxicity. Thus an empirical approach is recommended for selecting the optimal GEVI.
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